AAAASF names new president

The American Association for Accreditation of Ambulatory Surgery Facilities has appointed one of its board members the new leader of the organization.

David Watts, MD, who was elected Oct. 15, had served on the board since 2010, AAAASF said in a statement to HealthExec. He has work on the standards, education committee, innovation and business development committees.

“I am honored to have been chosen as the next leader of this extraordinary association,” Watts said. “For nearly 40 years, AAAASF board members and staff have worked tirelessly to ensure patient safety in our accredited facilities. I look forward to propelling the organization into an exciting future that holds considerable opportunities.”

He is the founder and CEO of the Plastic and Cosmetic Surgery Institute in Vineland, New Jersey, and the CEO of Ambulatory Surgical Center and Watts Plastic Surgery Association, also in Vineland.

Watts holds a bachelor’s in biology from Cheyney University of Pennsylvania in Cheyney, Pennsylvania, and MD from Jefferson Medical College in Philadelphia.

Katherine Davis,

Senior Writer

As a Senior Writer for TriMed Media Group, Katherine primarily focuses on producing news stories, Q&As and features for Cardiovascular Business. She reports on several facets of the cardiology industry, including emerging technology, new clinical trials and findings, and quality initiatives among providers. She is based out of TriMed's Chicago office and holds a bachelor's degree in journalism from Columbia College Chicago. Her work has appeared in Modern Healthcare, Crain's Chicago Business and The Detroit News. She joined TriMed in 2016.

Around the web

American College of Cardiology President B. Hadley Wilson, MD, discussed why the ACC and other leading cardiology groups are so eager to create a new, independent medical board. This has been a long-term goal for many years, he said, and now it may become a reality. 

Last week brought the latest in an occasional series of conversations on AI between governmental leaders and Big Tech honchos.

Programs managed by H-E-B, Kroger, Mark Cuban Cost Plus Drug Company and Walmart appear to offer the most options for CVD patients. When it comes to AFib and heart failure, however, researchers believe the choices could be improved. 

Trimed Popup
Trimed Popup